MIP-170D

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMIP-170D
Drug Alias Nameradiolabeled dopamine transporter ligand (Molecular Insight)MIP-170D
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityParkinson DiseaseCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Insight Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityParkinson DiseaseCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A